NCT00860548View on ClinicalTrials.gov

SCOT Scleroderma Treatment Alternative Registry (STAR Registry)

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Scleroderma, SystemicSclerosis
Interventions
DRUG

currently available therapy in the community

Participants will receive telephone calls every 3 months for approximately 44 months for the purpose of outcome surveys

Trial Locations (1)

77030

University of Texas, Houston Medical School, Houston

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00860548 - SCOT Scleroderma Treatment Alternative Registry (STAR Registry) | Biotech Hunter | Biotech Hunter